Drawing for ANGEX

USPTO serial 73227516

ANGEX

Reviewed by CopyMark Law Group

Reg. 1151446Status 711
Filing date
Status date
Registration date
Apr 21, 1981
Examiner
Law office
FILE DESTROYED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ANGEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JOHN J. HELDRICH

JOHN J HELDRICH JOHNSON & JOHNSONONE JOHNSON & JOHNSON PLZNEW BRUNSWICK, NJ 08933-7001UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Cardiovascular DrugSECTION 7(e) - CANCELLEDMar 1, 1979

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 23, 1987C7..CANCELLED SECTION 7-TOTAL
Aug 17, 1987C7RFREQUEST FOR SECT 7 TOTAL SURRENDER FILED
Dec 16, 1986C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Aug 22, 1986815FREGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Apr 21, 1981R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 27, 1981PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.

Frequently asked questions

Related guidance